Genetic Technologies (AU:GTG) has released an update.
Genetic Technologies Limited has announced an extension of the closing date for its Non-renounceable Entitlement Offer to allow eligible shareholders more time for consideration. Despite underwriting by the Directors, the offer has not yet reached its minimum subscription goal of $2 million, with interest currently just under $1 million. The offer, priced at $0.04 per New Share, aims to raise up to $3.88 million and is open to shareholders in Australia and New Zealand, excluding U.S. residents.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.
